Knockdown of asparagine synthetase by RNAi suppresses cell growth in human melanoma cells and epidermoid carcinoma cells

详细信息    查看全文

• 作者：Hui Li ; Fusheng Zhou ; Wenhui Du ; Jinfa Dou ; Yu Xu ; Wanwan Gao ; Gang Chen ; Xianbo Zuo ; Liangdan Sun ; Xuejun Zhang and Sen Yang
• 刊名：Biotechnology and Applied Biochemistry
• 出版年：2016
• 出版时间：May/June 2016
• 年：2016
• 卷：63
• 期：3
• 页码：328-333
• 全文大小：601K
• ISSN：1470-8744

文摘

Melanoma, the most aggressive form of skin cancer, causes more than 40,000 deaths each year worldwide. And epidermoid carcinoma is another major form of skin cancer, which could be studied together with melanoma in several aspects. Asparagine synthetase (ASNS) gene encodes an enzyme that catalyzes the glutamine- and ATP-dependent conversion of aspartic acid to asparagine, and its expression is associated with the chemotherapy resistance and prognosis in several human cancers. The present study aims to explore the potential role of ASNS in melanoma cells A375 and human epidermoid carcinoma cell line A431. We applied a lentivirus-mediated RNA interference (RNAi) system to study its function in cell growth of both cells. The results revealed that inhibition of ASNS expression by RNAi significantly suppressed the growth of melanoma cells and epidermoid carcinoma cells, and induced a G0/G1 cell cycle arrest in melanoma cells. Knockdown of ASNS in A375 cells remarkably downregulated the expression levels of CDK4, CDK6, and Cyclin D1, and upregulated the expression of p21. Therefore, our study provides evidence that ASNS may represent a potential therapeutic target for the treatment of melanoma.